146 related articles for article (PubMed ID: 33795350)
1. Inhibition of Human Uracil DNA Glycosylase Sensitizes a Large Fraction of Colorectal Cancer Cells to 5-Fluorodeoxyuridine and Raltitrexed but Not Fluorouracil.
Christenson ES; Gizzi A; Cui J; Egleston M; Seamon KJ; DePasquale M; Orris B; Park BH; Stivers JT
Mol Pharmacol; 2021 Jun; 99(6):412-425. PubMed ID: 33795350
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of uracil DNA glycosylase sensitizes cancer cells to 5-fluorodeoxyuridine through replication fork collapse-induced DNA damage.
Yan Y; Han X; Qing Y; Condie AG; Gorityala S; Yang S; Xu Y; Zhang Y; Gerson SL
Oncotarget; 2016 Sep; 7(37):59299-59313. PubMed ID: 27517750
[TBL] [Abstract][Full Text] [Related]
3. Loss of Uracil DNA Glycosylase Selectively Resensitizes p53-Mutant and -Deficient Cells to 5-FdU.
Yan Y; Qing Y; Pink JJ; Gerson SL
Mol Cancer Res; 2018 Feb; 16(2):212-221. PubMed ID: 29117941
[TBL] [Abstract][Full Text] [Related]
4. A novel polypyrimidine antitumor agent FdUMP[10] induces thymineless death with topoisomerase I-DNA complexes.
Liao ZY; Sordet O; Zhang HL; Kohlhagen G; Antony S; Gmeiner WH; Pommier Y
Cancer Res; 2005 Jun; 65(11):4844-51. PubMed ID: 15930305
[TBL] [Abstract][Full Text] [Related]
5. Uracil incorporation into genomic DNA does not predict toxicity caused by chemotherapeutic inhibition of thymidylate synthase.
Luo Y; Walla M; Wyatt MD
DNA Repair (Amst); 2008 Feb; 7(2):162-9. PubMed ID: 17942376
[TBL] [Abstract][Full Text] [Related]
6. Genomically Incorporated 5-Fluorouracil that Escapes UNG-Initiated Base Excision Repair Blocks DNA Replication and Activates Homologous Recombination.
Huehls AM; Huntoon CJ; Joshi PM; Baehr CA; Wagner JM; Wang X; Lee MY; Karnitz LM
Mol Pharmacol; 2016 Jan; 89(1):53-62. PubMed ID: 26494862
[TBL] [Abstract][Full Text] [Related]
7. Expression of uracil DNA glycosylase (UDG) does not affect cellular sensitivity to thymidylate synthase (TS) inhibition.
Welsh SJ; Hobbs S; Aherne GW
Eur J Cancer; 2003 Feb; 39(3):378-87. PubMed ID: 12565992
[TBL] [Abstract][Full Text] [Related]
8. Effect of the thymidylate synthase inhibitors on dUTP and TTP pool levels and the activities of DNA repair glycosylases on uracil and 5-fluorouracil in DNA.
Grogan BC; Parker JB; Guminski AF; Stivers JT
Biochemistry; 2011 Feb; 50(5):618-27. PubMed ID: 21222484
[TBL] [Abstract][Full Text] [Related]
9. UNG-initiated base excision repair is the major repair route for 5-fluorouracil in DNA, but 5-fluorouracil cytotoxicity depends mainly on RNA incorporation.
Pettersen HS; Visnes T; Vågbø CB; Svaasand EK; Doseth B; Slupphaug G; Kavli B; Krokan HE
Nucleic Acids Res; 2011 Oct; 39(19):8430-44. PubMed ID: 21745813
[TBL] [Abstract][Full Text] [Related]
10. An effective human uracil-DNA glycosylase inhibitor targets the open pre-catalytic active site conformation.
Nguyen MT; Moiani D; Ahmed Z; Arvai AS; Namjoshi S; Shin DS; Fedorov Y; Selvik EJ; Jones DE; Pink J; Yan Y; Laverty DJ; Nagel ZD; Tainer JA; Gerson SL
Prog Biophys Mol Biol; 2021 Aug; 163():143-159. PubMed ID: 33675849
[TBL] [Abstract][Full Text] [Related]
11. The mismatch repair-mediated cell cycle checkpoint response to fluorodeoxyuridine.
Liu A; Yoshioka K; Salerno V; Hsieh P
J Cell Biochem; 2008 Sep; 105(1):245-54. PubMed ID: 18543256
[TBL] [Abstract][Full Text] [Related]
12. Fluorodeoxyuridine modulates cellular expression of the DNA base excision repair enzyme uracil-DNA glycosylase.
Fischer JA; Muller-Weeks S; Caradonna SJ
Cancer Res; 2006 Sep; 66(17):8829-37. PubMed ID: 16951200
[TBL] [Abstract][Full Text] [Related]
13. 5-Fluorouracil incorporated into DNA is excised by the Smug1 DNA glycosylase to reduce drug cytotoxicity.
An Q; Robins P; Lindahl T; Barnes DE
Cancer Res; 2007 Feb; 67(3):940-5. PubMed ID: 17283124
[TBL] [Abstract][Full Text] [Related]
14. dUTPase inhibition confers susceptibility to a thymidylate synthase inhibitor in DNA-repair-defective human cancer cells.
Yokogawa T; Yano W; Tsukioka S; Osada A; Wakasa T; Ueno H; Hoshino T; Yamamura K; Fujioka A; Fukuoka M; Ohkubo S; Matsuo K
Cancer Sci; 2021 Jan; 112(1):422-432. PubMed ID: 33140501
[TBL] [Abstract][Full Text] [Related]
15. SMUG1 but not UNG DNA glycosylase contributes to the cellular response to recovery from 5-fluorouracil induced replication stress.
Nagaria P; Svilar D; Brown AR; Wang XH; Sobol RW; Wyatt MD
Mutat Res; 2013; 743-744():26-32. PubMed ID: 23253900
[TBL] [Abstract][Full Text] [Related]
16. Checkpoint signaling, base excision repair, and PARP promote survival of colon cancer cells treated with 5-fluorodeoxyuridine but not 5-fluorouracil.
Geng L; Huehls AM; Wagner JM; Huntoon CJ; Karnitz LM
PLoS One; 2011; 6(12):e28862. PubMed ID: 22194930
[TBL] [Abstract][Full Text] [Related]
17. Human ribosomal protein S3 (hRpS3) interacts with uracil-DNA glycosylase (hUNG) and stimulates its glycosylase activity.
Ko SI; Park JH; Park MJ; Kim J; Kang LW; Han YS
Mutat Res; 2008 Dec; 648(1-2):54-64. PubMed ID: 18973764
[TBL] [Abstract][Full Text] [Related]
18. Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil.
Kunz C; Focke F; Saito Y; Schuermann D; Lettieri T; Selfridge J; Schär P
PLoS Biol; 2009 Apr; 7(4):e91. PubMed ID: 19402749
[TBL] [Abstract][Full Text] [Related]
19. A novel combination antimetabolite, TAS-102, exhibits antitumor activity in FU-resistant human cancer cells through a mechanism involving FTD incorporation in DNA.
Emura T; Suzuki N; Yamaguchi M; Ohshimo H; Fukushima M
Int J Oncol; 2004 Sep; 25(3):571-8. PubMed ID: 15289858
[TBL] [Abstract][Full Text] [Related]
20. Analysis of uracil DNA glycosylase in human colorectal cancer.
Dusseau C; Murray GI; Keenan RA; O'Kelly T; Krokan HE; McLeod HL
Int J Oncol; 2001 Feb; 18(2):393-9. PubMed ID: 11172609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
